CClinicalTrials.gg
Sign In
Status unknownNCT03736824Updated Nov 9, 2018

Correlation of Endoscopic Findings and Symptoms in Patients Undergoing the First Upper Gastrointestinal Endoscopy

An observational study in Symptoms and Signs, Malignancy and Ulcer Peptic, sponsored by Shanghai Jiao Tong University School of Medicine. Status unknown at 1 site in China. Per ClinicalTrials.gov, last updated 2018-11-09.

Sponsored by Shanghai Jiao Tong University School of Medicine · Observational

The sponsor has not verified this record recently (last verified Nov 2018), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
5,000
Sex
All
01

Study summary

Endoscopy is the best means of finding early stage of upper gastrointestinal diseases, especially early cancer and benign ulcers. Currently, most people still undergo upper gastrointestinal endoscopy due to discomfort, rather than a regular physical examination at a certain age. This study prospectively investigated the reason for undergoing the first upper gastrointestinal endoscopy in patients and found the correlation of endoscopic findings and symptoms.

02

Conditions studied

  • Symptoms and Signs
  • Malignancy
  • Ulcer Peptic

Browse trials for

03

In context

Peptic Ulcer

193 studies on the registry are indexed under Peptic Ulcer; 31 are open to participants now.

This study's planned enrollment of 5,000 is above the median of 391 across 43 observational studies indexed under Peptic Ulcer.

Browse Peptic Ulcer studies →

Lead sponsor

Shanghai Jiao Tong University School of Medicine is the lead sponsor of 358 studies on the registry; 104 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients undergoing the first upper gastrointestinal endoscopy were collected from January 2018 to December 2018 in Renji Hospital, Shanghai Jiaotong University School of Medicine.

Inclusion criteria

  • Patients undergoing the first upper gastrointestinal endoscopy.

Exclusion criteria

Exclusion Criteria:

  • The patients had previously performed endoscopy and any esophageal, gastric or duodenal surgery.
  • The patients couldn't complete the questionnaire survey under the guidance of physicians at the appointment of the upper gastrointestinal endoscopy.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
5,000 participants (estimated)
Patient registry
No

Interventions

  • Procedureendoscopy

    All endoscopy was performed by qualified gastroenterologists or endoscopic physicians in Renji hospital,Shanghai Jiaotong University School of Medicine.

06

What researchers measure

Primary outcomes

  1. Correlation of endoscopic findings and symptoms

    survey

    Time frame: Within two weeks after receiving the survey

Secondary outcomes

  1. The proportion of various symptoms in patients undergoing the first upper gastrointestinal endoscopy

    Time frame: Within two weeks after receiving the survey

  2. The proportion of different upper gastrointestinal diseases

    Diagnosis of upper gastrointestinal disease combined with endoscopic findings and pathological diagnosis.

    Time frame: Within two weeks after receiving the survey

  3. The infection rate of Helicobacter Pylori

    H. pylori infection was determined by any two of positive outcome of the breath test, rapid urease test and histology.

    Time frame: Within two weeks after receiving the survey

07

Study locations

1 of 1 sites recruiting
  • Renji Hospital, Shanghai Jiaotong University School of Medicine
    Shanghai, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 9, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03736824
Lead sponsor
Shanghai Jiao Tong University School of Medicine
Responsible party
Hong Lu, MD (Medical Doctor of Division of Gastroenterology and Hepatology of Renji Hospital,Professor of Medicine, Shanghai Jiao Tong University School of Medicine) — Principal investigator
First posted
Nov 9, 2018
Start date
Jan 1, 2018
Primary completion
Nov 30, 2018 (estimated)
Completion
Dec 31, 2018 (estimated)
Last update
Nov 9, 2018

Study contacts

Huiyi Li
Contact
lhy177279@163.com
+8613761902402
Hong Lu
study director · School of Medicine, Shanghai Jiao Tong University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Peptic Ulcer→

Other studies from this sponsor

Shanghai Jiao Tong University School of Medicine

Start the discussion